ArticleInternational journal of stroke : official journal of the International Stroke Society2022

Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.

Andrew M Naidech et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.